305 POSTER Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients

2006 ◽  
Vol 32 ◽  
pp. S92
Author(s):  
F. Fitzal ◽  
E. Sporn ◽  
W. Draxler ◽  
M. Mittlböck ◽  
O. Riedl ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Local Recurrence ◽  
Cancer Patients ◽  
Recurrence Rate ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Local Recurrence Rate ◽  
Breast Cancer Patients ◽  
Core Needle

Preoperative Core Needle Biopsy does not Increase Local Recurrence Rate in Breast Cancer Patients

2006 ◽  
Vol 97 (1) ◽  
pp. 9-15 ◽  
Author(s):  
Florian Fitzal ◽  
Emanuel P. Sporn ◽  
Wolfgang Draxler ◽  
Martina Mittlböck ◽  
Susanne Taucher ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Local Recurrence ◽  
Cancer Patients ◽  
Recurrence Rate ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Local Recurrence Rate ◽  
Breast Cancer Patients ◽  
Core Needle

Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 815-815
Author(s):  
F. Fitzal ◽  
E. Sporn ◽  
W. Draxler ◽  
S. Taucher ◽  
M. Rudas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Local Recurrence ◽  
Cancer Patients ◽  
Recurrence Rate ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Local Recurrence Rate ◽  
Breast Cancer Patients ◽  
Core Needle

scholarly journals Strategy for Diagnosing Breast Cancer in Indonesia during the COVID-19 Pandemic: Switching to Ultrasound-Guided Percutaneous Core Needle Biopsy

2021 ◽  
Vol 16 (3) ◽  
Author(s):  
Farida Briani Sobri ◽  
Adang Bachtiar ◽  
Sonar Soni Panigoro ◽  
Juwita Cresti Rahmaania ◽  
Patria Wardana Yuswar ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Hospital Environment ◽  
Breast Cancer Patients ◽  
Ultrasound Guided ◽  
Core Needle ◽  
The Us ◽  
Percutaneous Core Needle Biopsy

In this era of COVID-19, suspected breast cancer patients experience delay in diagnosis due to the fear of contracting the virus and reduction of non-COVID-19 health services. Furthermore, it may lead to potential increase in the incidence of advanced cancers in the future. Ultrasound-guided (US-guided) percutaneous core needle biopsy (CNB) is a great option for the diagnosis of cancer but it is poorly utilized. This study aimed to prove that the US-guided CNBis accurate when performed in a local setting and a potential solution for diagnosing breast cancer patients in this pandemic. In addition, it was a single health center cross-sectional study, and the participants were all breast cancer patients that had US-guided CNB from 2013-2019. The pathology results from US-guided CNB were compared to specimens from post-CNB surgeries. The data were collected from medical records and the immunohistochemistry (IHC) examinations were carried out for malignancy. There were 163 patients who were included in this study, 86 had malignancies and 77 had benign tumor reported in their CNB results. The US-guided CNB had 100% sensitivity and specificity compared to surgery. With its lower cost, time usage, and patient exposure to the hospital environment, US-guided CNB should replace open surgery biopsy for diagnosing suspicious breast cancers during the pandemic in Indonesia.

Reliability of receptor assessment on core needle biopsy in breast cancer patients

Tumor Biology ◽  
2012 ◽  
Vol 34 (2) ◽  
pp. 987-994 ◽  
Author(s):  
S. C. Seferina ◽  
M. Nap ◽  
F. van den Berkmortel ◽  
J. Wals ◽  
A. C. Voogd ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Core Needle Biopsy ◽  
Needle Biopsy ◽  
Breast Cancer Patients ◽  
Core Needle
Sign in / Sign up

Export Citation Format

Share Document